ClinicalTrials.Veeva

Menu

High Flow Therapy in ICUs Across Ibero America (T-Calfi)

F

Fundación Santa Fe de Bogota

Status

Unknown

Conditions

Ventilatory Failure
Hypercapnic Respiratory Failure
Hypoxia
Intensive Care Unit
Nasal High Flow Therapy

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03364946
CCEI-7327-2017

Details and patient eligibility

About

The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of participating centers in Iberoamerica. It will describe the indications for the use, the clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying in an intensive care unit in the participant centers in Iberoamerica.

Enrollment

255 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years old
  • Admitted to medical or surgical ICU
  • Requirement of high nasal flow therapy

Exclusion criteria

  • Post-extubation failure
  • Patient unable to protect airway
  • Diagnosed shock
  • Glasgow equal or under 8

Trial design

255 participants in 1 patient group

High Nasal Flow Therapy
Description:
Every patient in the ICU that requires High Nasal Flow Therapy
Treatment:
Other: No intervention

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems